Why These 5 Stocks Are Trending on Tuesday

2. Eli Lilly and Company (NYSE:LLY) is up 1% after the company reported third quarter earnings of $1.94 a share and revenue of $6.77 billion. The company has also initiated the rolling submission for donanemab to the FDA for potential accelerated approval in early Alzheimer’s disease. Fisher Asset Management owned more than 6 million shares of Eli Lilly and Company (NYSE:LLY) at the end of Q2.